Penumbra Quick Ratio 2014-2022 | PEN

Historical quick ratio values for Penumbra (PEN) over the last 10 years.
Penumbra Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2022-09-30 $0.40B $0.14B 2.92
2022-06-30 $0.42B $0.15B 2.90
2022-03-31 $0.42B $0.13B 3.20
2021-12-31 $0.42B $0.12B 3.39
2021-09-30 $0.41B $0.12B 3.53
2021-06-30 $0.40B $0.11B 3.69
2021-03-31 $0.39B $0.11B 3.49
2020-12-31 $0.40B $0.11B 3.76
2020-09-30 $0.40B $0.11B 3.69
2020-06-30 $0.39B $0.08B 5.06
2020-03-31 $0.29B $0.09B 3.27
2019-12-31 $0.31B $0.09B 3.41
2019-09-30 $0.31B $0.09B 3.61
2019-06-30 $0.30B $0.07B 4.33
2019-03-31 $0.30B $0.07B 4.34
2018-12-31 $0.30B $0.07B 4.47
2018-09-30 $0.29B $0.07B 4.43
2018-06-30 $0.30B $0.05B 5.94
2018-03-31 $0.29B $0.05B 5.84
2017-12-31 $0.29B $0.05B 5.57
2017-09-30 $0.28B $0.05B 5.51
2017-06-30 $0.28B $0.04B 7.56
2017-03-31 $0.29B $0.04B 7.60
2016-12-31 $0.19B $0.04B 5.33
2016-09-30 $0.20B $0.04B 5.28
2016-06-30 $0.19B $0.03B 5.96
2016-03-31 $0.19B $0.03B 5.51
2015-12-31 $0.19B $0.03B 6.67
2015-09-30 $0.20B $0.03B 7.03
2015-06-30 $0.00B 0.00
2015-03-31 $0.00B 0.00
2014-12-31 $0.00B 0.00
2014-09-30 $0.00B 0.00
2013-12-31 $0.04B $0.02B 2.22
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $8.008B $0.748B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $220.806B 23.09
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00